Rivaroxaban is a direct oral anticoagulant (DOAC) that effectively thins the blood to prevent and treat potentially dangerous blood clots. It is widely prescribed to lower the risk of stroke in patients with nonvalvular atrial fibrillation and to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).